
|Articles|March 27, 2008
DT April e-news art
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
3
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
4
Practical Approaches to Managing Atopic Dermatitis With Topical Therapies
5

















